A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia

NCT01670071 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
17
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated due to insufficient sample size and protocol compliance issue.

Conditions

Interventions

Sponsor

Johnson & Johnson Taiwan Ltd